Impact of Chemotherapy Delay on Overall Survival for AML With I DH1/2 Mutations: A Study in Adult Chinese Patients

Blood - United States
doi 10.1182/blood.v126.23.4905.4905
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

The Combination of NPM1, DNMT3A and IDH1/2 Mutations Leads to Inferior Overall Survival in AML

American Journal of Hematology
Hematology
2019English

Impact of Comorbidity on Overall Survival in Patients Surgically Treated for Renal Cell Carcinoma

Urology
Urology
2008English

Table 2: Clinical Variables and Survival of Patients With Stage I/Ii SCLC in the Cox Proportional Hazards Model for Overall Survival.

English

Hypertension and Overall Survival in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Containing Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2011English

Impact of &Quot;Conversation Maps" On Diabetes Distress and Self-Efficacy of Chinese Adult Patients With Type 2 Diabetes: A Pilot Study

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2016English

Impact of Surgery Type on the Overall Survival Time of Patients With Primary Brain Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

P026 Impact of Prior Cancer History on the Overall Survival of Younger Patients With Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab

Clinical Medicine Insights: Oncology
Oncology
2019English

P3.01-09 Impact of Urban or Rural Residence on Overall Survival for Patients With Metastatic Non-Squamous NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy